News

genXtraits, Mendel Biotechnology and AgGene Announce Collaboration to Develop Stress-Resilient Canola Traits

June 10, 2026

SAN FRANCISCO, June 10, 2026 (GLOBE NEWSWIRE) -- San Francisco Bay Area based biotechnology firms, genXtraits Inc. (genXtraits) and Mendel Biotechnology, Inc. (Mendel), have announced a joint collaboration with AgGene Inc. (AgGene), a Canadian plant biotechnology company focused on canola trait development. Under the terms of the agreement, AgGene has received royalty-bearing commercial licenses under genXtraits’ and Mendel’s respective intellectual property estates, enabling the development of novel variants of key regulatory genes associated with yield, stress resilience and crop performance. [Globe Newswire]

genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration

August 20, 2025

ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- San Francisco Bay Area-based crop biotechnology firms genXtraits, Inc. (genXtraits) and Mendel Biotechnology, Inc. (Mendel) have announced that they have entered a collaboration to develop new crop traits. Under the terms of the deal, Mendel has received a non-controlling, minority ownership position in genXtraits.

The aim of the partnership is to deliver a next generation of genetic traits that enable the commercialization of new crop varieties with improved nutritional content, lower requirements for inputs such as water and fertilizer, and which are adapted to maintain yield and performance in the face of a changing climate. [Globe Newswire]

Syntopa enters collaboration with Mendel Biotechnology

May 9, 2025

ALAMEDA, CA, UNITED STATES -- Syntopa Inc (Syntopa) has announced that it has entered a license agreement with SF Bay Area-based crop trait technology provider, Mendel Biotechnology, Inc. (Mendel).

Under the terms of the relationship, Syntopa will be granted access to Mendel intellectual property, including a proprietary collection of plant germplasm, to enable the discovery and development of new technology to enhance carbon and nitrogen capture. Syntopa will receive exclusive rights to commercialize products that result from the project. [EIN Presswire]